Take-Home Messages
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Treatment resistance is common in OCD. Approximately 40% to 60% of patients meet criteria for treatment resistance despite an integrated approach. SSRIs remain the pharmacologic treatment of choice for OCD, even after multiple SSRI failures. OCD guidelines recommend using them at doses above FDA recommendations. The recommended sequence for augmenting OCD treatment starts with clomipramine as first option, followed by glutamatergic agents and then second-generation antipsychotics if needed.
Fields of Study & Subjects
Obsessive-Compulsive Spectrum Disorders
Anxiety
Depression
Psychometrics
Treatment
Cognitive Processes
Psychoanalysis and Psychopathology Research
Publication details
- Publication date
- 1 February 2026
- Language
- EN